The antitumor effect of IFNβ is directly mediated by effects on proliferation, cell cycle, or apoptosis, and indirectly by immune activation.2 IFNβ also has anti-inflammatory effects, which make it the most important drug for MS patients. The gene discussed is IFNB1; the disease is myeloid sarcoma.